top
Search terms
Results 1 - 4 of 4 - ordered by :
Ehjcvp

Abstract Aims Clinical utilization of dual antiplatelet therapy (DAPT) in patients with renal impairment (RI) following percutaneous coronary interventions (PCI) represents an urgent, unmet need ...

European Heart Journal - Cardiovascular Pharmacotherapy, ORIGINAL ARTICLES, Long Zhe Guo, Moo Hyun Kim, Chang Heon Shim, Sun Young Choi, Victor L. Serebruany

Date : 01/07/2016
Ehjcvp

A recently published postmarketing study has shown that dabigatran causes a significantly higher risk of extracranial bleeding than VKAs in clinical practice.3 It was also found that NVAF patients ...

European Heart Journal - Cardiovascular Pharmacotherapy, EDITORIALS, Herbert J.A. Rolden, Janneke P.C. Grutters, Gert Jan van der Wilt, Angela H.E.M. Maas

Date : 01/07/2015
Ehjcvp

New oral anticoagulants are used in atrial fibrillation (AF) patients to prevent strokes in the primary and secondary prevention settings.1,2 Since AF are reported to be an independent risk factor ...

European Heart Journal - Cardiovascular Pharmacotherapy, EDITORIALS, Shinichi Goto, Shinya Goto

Date : 01/04/2015 Item size : 186244 bytes
Ehjcvp

Glycoprotein IIb/IIIa receptor inhibitors (GPIs) block the final common pathway leading to platelet aggregation that occurs via the cross-linking of fibrinogen and von Willebrand factor upon exposure ...

European Heart Journal - Cardiovascular Pharmacotherapy, ORIGINAL ARTICLES, Jeffrey D. Wessler, Robert P. Giugliano

Date : 01/04/2015